Respiratory Syncytial Virus Research Paper

Acute bronchitis is one of the most common diagnoses encountered in a primary care setting. It affects millions of individuals resulting in significant impact on health of patients and health care industry. Studies have shown that 90% of times acute bronchitis is caused by a virus, yet health care providers are failing to treat or manage these patients with appropriate therapies (Knutson & Braun, 2002). The focus of this paper is to review the guidelines for treatment of acute bronchitis after differentiating acute bronchitis from other common respiratory disease in terms of epidemiology, pathophysiology, clinical features, diagnosis, differential diagnosis, complications and patient education. Understanding the evaluation and treatment guidelines, nurse practitioners can provide evidence-based practice for patients with acute bronchitis.

Respiratory Syncytial Virus (RSV) causes acute respiratory tract infection in patients of all ages and is one of the most popular diseases of childhood. Respiratory syncytial virus (RSV) infection, which manifests primarily as bronchiolitis and/or viral pneumonia, is the leading cause of lower respiratory tract (LRT) infection in infants and young children. RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lungs) and pneumonia in children under one year of age in the United States. During the first year of life, most infants are infected with the virus. Most RSV infected children encounter

Each year more than 90,000 infants are hospitalized with the RSV infection, and nearly 75% of bronchiolitis cases and more than 50% of pneumonia cases are hospitalized also because of the infection. The infection usually lasts from four to twenty-one days. If the infection is severe it could last a lot longer. By the age of two most children has had the infection. There are new developments in the diagnosis, treatment, and prevention of RSV infection in infants and children. Early childhood recognition can help to minimize the morbidity and

Respiratory syncytial virus (RSV) has a seasonal and yearly incidence, usually between November and April. It is responsible for high infant morbidity and mortality worldwide.. By the first year of life, 60% of children are infected, and almost 100% are infected by 2 years of age. (Saso,&Kampmann,2016). The more common age for hospitalizations occur between 2-3 months of age, and is the leading cause of infants being hospitalized in the developed world, accounting for 2 % of admissions during the winter season. (geerdink,Pillay,Meyalard,2015). The natural RSV infection in those younger than 6 months does not adequately develop a long-lasting immunological response, making reoccurrence of infection likely to reoccur. RSV is an infection that causes cold-like illness that can also cause otitis media, rhinitis, bronchitis, croup, and, pneumonia. Although RSV can cause different reactions, Bronchiolitis is the most common form of occurrence in the pediatric population. This virus is very caustic to the respiratory lining for vulnerable infants, that it increases the risk for respiratory diseases in later years of childhood.

Middle East Respiratory Syndrome (MERS) is a severe acute respiratory illness caused by the coronavirus named MERS-CoV. It is believed that the virus is found in camels and passed on to humans who are in contact or around infected animal. These camels are mainly located in Egypt, Oman, Qatar, and Saudi Arabia (WHO, 2015a). Those infected with MERS exhibit fever, cough, and shortness of breath, pneumonia, and diarrhea. Severe cases require patient to be put on mechanical ventilation or in an intensive care unit. It is also known to cause kidney failure and septic shock. The elderly, persons who are immunosuppressed, those who

In September of 2012, beginning in the country of Saudi Arabia, hospitals began seeing increased cases of a respiratory virus never before seen in humans. They named it Middle East Respiratory Syndrome, or MERS. MERS is a viral respiratory illness caused by the coronavirus. It was originally thought to have started there in Saudi Arabia. It was not until later that they were able to trace the origin back to Jordan starting in April of 2012. All outbreaks of MERS have been traced back to originating from the Arabian Peninsula (CDC, 2015a). Unfortunately, it is not known exactly how MERS was contracted in humans, but it is believed to have come from an animal source, probably from camels. Strains of MERS

When children or young people are unwell or injured inform the designated first aider, ensure the surrounding environment is safe. Assess signs and symptoms and take appropriate action and inform parent/carers. For e.g. a child is not acting themselves, feels hot to touch. Then remove clothing as necessary, use a cold flannel to cool them down. Make them comfortable and take their temperature. Ensure this is recorded in an incident log. Inform the parent/carer that the child is unwell and to come and collect them if

RSV is the most common cause of LRTI’s leading to morbidity and mortality in children across the world. Most children have acquired an RSV infection by the time they reach 2 years of age. It is typical to see these infections during the winter/early spring seasons in temperate regions, and during the rainy seasons in tropical areas. This is likely due to the increase of indoor crowding related to weather. The transmission of RSV requires close contact by either a large particle aerosol, or by contamination of hands followed by an inoculation into the eye or nose. Secondary infections are seen in in family contacts of an individual with a primary case due to their close contact.

Nipah virus, Arena Virus and Francisella tularensis are bioterrorism agents. They work in various ways to harm the host. Francisella tularenis is considered a Tier 1 bioterrorism agent and Nipah virus is an overlap select agent that affects humans and agriculture both. They have been harmful in the past. Though, Nipah virus is a newer virus than the other two. This review will focus on their emergence, pathogenicity and symptoms of the diseases they cause.

RSV comes into the airway epithelium from the apical side only and aims to destroy the ciliated epithelia cells (4). Then RSV buds and releases the virus from the apical surface (4).

A mother brings their toddler in to the clinic, with what they think is a cold but a nurse wonders if the child could possibly have respiratory syncytial virus (RSV). A cold and RSV are a lot alike, in the way that they both may come across as “cold-like symptoms,” but this is not the case. Throughout this report one will find out what the differences between a common cold and RSV are, the signs and symptoms a toddler may have with this virus, the treatments one may face and ways to prevent this awful and dangerous virus. The purpose of this report is to deepen one’s understanding of the respiratory syncytial virus and explain the dangerous

The tests are best for younger children as many high school students understand what kinds of content can land them in trouble.

Blood gas analysis may be performed to determine if high concentration oxygen therapy is needed (Bush & Thomson, 2007). The management of fever would be a part of care plan when the infant is febrile due to infection (Axton & Fugate 2009).

Infectious disease is considered an ever evolving issue world-wide. A number of health officials and idealists believed that the threat of infectious disease would have been eradicated by now.1 Infectious disease remains the leading cause of death across the globe and the third leading cause of death in the United States.2 Within the scope of infectious disease, the most common cause of illness is viral respiratory tract infections, also referred to as VRTI.3 Recently, a new strain of virus related to the Severe Acute Respiratory Syndrome commonly referred to as SARS has been identified.4,5 The Middle East Respiratory Syndrome is a viral infection that affects the respiratory tract in humans and has recently been discovered in a small

Respiratory symptoms of this virus can be fever, cough, shortness of breath, and pneumonia. Patients can also have gastrointestinal problems such as diarrhea. If the patient becomes severely ill, they may have a respiratory failure and would be placed on a respirator or a ventilator. According to the World Health Organization (WHO) website, "Approximately 27% of patients with MERS have died." The organization also claims that the virus causes a severer disease in the elderly, people with a weak immune system, and people that may gave a chronic disease.